Skip to content

Gilead Sciences, Inc. Price, Chart & Factor Exposure

Free Data & Analytics Access
Gilead Sciences, Inc. · E.GILD.NEO · Canada
Use symbol E.GILD.NEO in our API & Excel add-in to retrieve this data ↓
—
(—)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum —
Trend —
Bubble Risk LOW
Realised Volatility (20D) —

Gilead Sciences, Inc. Price Chart

MacroFinance.ai

Gilead Sciences, Inc. Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Gilead Sciences, Inc.
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Gilead Sciences, Inc.
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Gilead Sciences, Inc.
Signal
0
ⓘLatest reading of Signal.
Teal = supportive for Gilead Sciences, Inc., red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Research on Gilead Sciences, Inc.

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

About Gilead Sciences, Inc. (Canada)

Gilead Sciences, Inc. is a listed security in Canada. This page shows the latest price and daily change, a price chart, its factor exposures and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on Gilead Sciences Inc

Frequently asked questions

What is Gilead Sciences, Inc.?
Gilead Sciences, Inc. is a listed security in Canada. On MacroFinance its page shows the latest price and daily change, a price chart, its factor exposures and free historical data.
What factors affect Gilead Sciences, Inc.?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Gilead Sciences, Inc., grouped as Quantitative Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Where can I download free Gilead Sciences, Inc. historical data?
In the Free historical data section of this page: the last 10 years of Gilead Sciences, Inc. daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Gilead Sciences, Inc. historical data (last 10 years)

Browse or instantly download the last 10 years of Gilead Sciences, Inc. daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.GILD.NEO&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-05-2927.31
2026-05-2827.58
2026-05-2727.23
2026-05-2627.32
2026-05-2527.1
2026-05-2227.27
2026-05-2126.5
2026-05-2026.54
2026-05-1926.51
2026-05-1526.34
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.